Cravens & Co Advisors »

Regeneron Pharmaceuticals shares owned by Cravens & Co Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Cravens & Co Advisors from 13F filings

Historical chart of Cravens & Co Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Cravens & Co Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Cravens & Co Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.4M 1.3k 1051.24
2024-06-30 $1.3M 1.2k 1051.03
2024-03-31 $1.2M 1.3k 962.49
2023-12-31 $1.1M 1.3k 878.29
2023-09-30 $1.1M 1.3k 822.96
2023-06-30 $883k 1.2k 718.54
2023-03-31 $1.0M 1.2k 821.67
2022-12-31 $900k 1.2k 721.49